[Histopathologic study on nephrotoxocity of tuberactinomycin-N, with special reference to interrelation between nephrotoxicity and ototoxicity (author's transl)].
D000818:Animals; D000904:Antibiotics, Antitubercular / Q000009:adverse effects*; D002207:Capreomycin / Q000009:adverse effects; D007758:Ear, Inner / Q000473:pathology*; D006168:Guinea Pigs; D007612:Kanamycin / Q000009:adverse effects; D007668:Kidney / Q000473:pathology*; D007674:Kidney Diseases / Q000139:chemically induced* / Q000473:pathology; D007759:Labyrinth Diseases / Q000139:chemically induced* / Q000473:pathology; D008722:Methods; D010455:Peptides / Q000009:adverse effects
D000904:Antibiotics, Antitubercular; D010455:Peptides; D002207:Capreomycin; D007612:Kanamycin